GENEDRIVE PLC Logo

GENEDRIVE PLC

Develops rapid, point-of-care pharmacogenetic testing platforms for personalized medicine.

GDR | IL

Overview

Corporate Details

ISIN(s):
GB00B1VKB244 (+2 more)
LEI:
213800ZYODIRZ87Y4K14
Country:
United Kingdom
Address:
THE INCUBATOR BUILDING, M13 9XX MANCHESTER

Description

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-11 10:10
New interactive investor hub
English 13.8 KB
2025-12-09 17:00
Agreement of Shareholder Loan
English 16.9 KB
2025-12-08 17:10
Annual Report and Accounts and date of AGM
English 13.1 KB
2025-12-05 08:20
Final Results
English 215.8 KB
2025-12-03 08:35
Notice of Results
English 13.7 KB
2025-12-01 16:30
Block Listing Returns
English 24.2 KB
2025-12-01 08:40
Results presented re. NHS CYP2C19 Genotype Testing
English 20.0 KB
2025-11-27 11:20
NHS implementation guide published for CYP2C19
English 16.9 KB
2025-11-26 08:25
Scotland national roll-out of MT-RNR1 ID Kit
English 15.3 KB
2025-11-19 08:25
Further re Shareholder Loan
English 17.3 KB
2025-11-04 08:30
MT-RNR1 ID Kit in Dublin’s Rotunda Hospital
English 14.8 KB
2025-10-31 08:00
Potential Shareholder Loan
English 13.2 KB
2025-10-24 17:30
Application for Listing & Total Voting Rights
English 12.6 KB
2025-10-10 14:32
Holding(s) in Company
English 52.5 KB
2025-10-10 14:31
Holding(s) in Company
English 23.9 KB

Automate Your Workflow. Get a real-time feed of all GENEDRIVE PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GENEDRIVE PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GENEDRIVE PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ARTELO BIOSCIENCES, INC. Logo
Clinical-stage biopharma developing therapeutics by modulating the endocannabinoid system.
United States of America
ARTL
Ascelia Pharma Logo
Biotechnology company developing and commercializing novel drugs for orphan oncology.
Sweden
ACE
Ascendis Pharma A/S Logo
Biopharmaceutical firm using its prodrug technology to treat rare diseases.
United States of America
ASND
ASCENTAGE PHARMA GROUP INTERNATIONAL Logo
A clinical-stage biopharma developing novel therapies for cancer and other diseases.
United States of America
AAPG
Specializes in hormone-related pharmaceuticals for internal medicine, OB/GYN, and urology.
Japan
4886
Aspire Biopharma Holdings, Inc. Logo
Develops sublingual drug delivery technologies for needle-free medications.
United States of America
ASBP
ASSEMBLY BIOSCIENCES, INC. Logo
A clinical-stage biotech developing small molecule antiviral therapeutics for viral diseases.
United States of America
ASMB
Assertio Holdings, Inc. Logo
Pharmaceutical company managing branded products for neurology and orphan diseases.
United States of America
ASRT
Astellas Pharma Inc. Logo
A global pharmaceutical company turning innovative science into value for patients.
Japan
4503
AstraZeneca PLC Logo
A global, science-led biopharmaceutical company developing prescription medicines.
United Kingdom
AZN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.